Modern Healthcare (complimentary online subscription): A federal advisory panel has chosen the influenza virus strains to be used in vaccine production for the 2016-17 flu season, alleviating some concerns about a possible supply shortage because of potential manufacturing delays.The U.S. Food and Drug Administration's advisory committee recommended the California variant for the H1N1 and Hong Kong variations of the H3N2 strains of the influenza virus.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now